Financials
Financials in One Page
Transocean's financials only make sense if you separate the underlying earnings power from the wreckage on the income statement. Revenue recovered from $2.6B in FY2021 to $4.0B in FY2025 (+55% over four years) as ultra-deepwater day rates re-rated, with Q1 FY2026 running at a $4.3B annualized pace. FY2025 net income was a $2.9B loss because Q2-Q3 2025 absorbed roughly $2.6B of non-cash rig impairments tied to fleet rationalization. Strip those out and Q4 FY2025 plus Q1 FY2026 show operating income of $240M and $287M, free cash flow for FY2025 was a real $626M (16% FCF margin, the best since 2015), and management used the cash to repay $1.56B of debt. The balance sheet is still levered (net debt $5.04B, CCC+ credit rating) but improving; ROIC has been negative for nine straight years; the stock at $6.37 trades at 0.75x book and 7.3x trailing free cash flow — a discount to Valaris and Noble on EV/Sales (2.3x vs 2.9-3.1x). The single metric that matters now is whether the post-impairment underlying earnings power — roughly $900M of normalized EBITDA — converts to sustained free cash flow large enough to drag net leverage below 3x by year-end 2026.
Revenue FY2025 ($M)
▲ 12.5% YoY
Free Cash Flow ($M)
▲ 15.8% FCF margin
Net Debt ($M)
Price / FCF (TTM)
Price / Book
ROIC FY2025
Glossary for the strip. Free cash flow is operating cash flow minus capex - the cash truly available after running the rigs. FCF margin is FCF divided by revenue. Net debt is total debt minus cash; it tells you the debt the equity actually has to absorb. Price / Book is share price divided by book value per share; under 1.0 means the market values the equity below stated accounting net worth. ROIC is return on invested capital - the economic return on every dollar tied up in the business; deeply negative means the rigs are not yet earning their cost of capital.
The FY2025 income statement is dominated by ~$2.6B of non-cash impairment charges booked in Q2-Q3 2025. Headline EBITDA prints negative, but operating cash flow is positive $749M and free cash flow is $626M. Read the cash flow statement, not the income statement, to understand earnings power this year.
Revenue, Margins, and Earnings Power
Revenue is the cleanest signal in this business and it is now in clear up-cycle. The trough was FY2021 at $2.56B. FY2025 closed at $3.97B (+12.5% YoY) and Q1 FY2026 came in at $1.08B - that's an annualized run-rate above $4.3B and the highest level since the 2016-2017 down-cycle. Day rates on the active ultra-deepwater fleet are anchoring the recovery.
Three things to read from this chart. First, this is a true commodity-cycle business: revenue swung from $11.98B in FY2008 to $2.56B in FY2021. Second, the FY2025 EBITDA print of -$1.68B is not operating reality - it includes the impairment hits Q2-Q3 2025. Third, the post-2017 plateau around $2.6-$4.0B is a fundamentally smaller company than the pre-2014 Transocean, which is why we anchor to current-cycle metrics rather than the 20-year mean.
Gross margin (revenue minus direct rig operating cost) is the most informative line because it strips out depreciation and impairments. Gross margin troughed at 30% in FY2023 and has rebounded to 39% in FY2025 - a clean signal that day rates are outrunning operating cost inflation. Operating margin and net margin are dragged down by depreciation on the rig base ($660M-$900M per year) and by lumpy impairment charges, so read those two lines as accounting metrics, not earnings power.
This chart is the single most important visual on the page. Revenue rose every quarter from 1Q24 to 1Q26, climbing from $763M to $1.08B. Operating income, ex-impairment, traced from breakeven into the +$240M / +$287M range in Q4 2025 and Q1 2026. The two enormous downward bars in Q2-Q3 2025 are non-cash impairments tied to fleet rationalization, not deterioration in the operating business. Strip them out and the underlying op-income run-rate annualizes to roughly $1.0-$1.1B.
Underlying earnings power has turned positive. The next four quarters must demonstrate that Q4 2025 / Q1 2026 was the new normal, not a tax-rate or one-off contract artifact.
Cash Flow and Earnings Quality
Reported net income has been negative every year from FY2017 to FY2025. Reported operating cash flow has been positive every year in that span - because rig depreciation and impairments are non-cash. This is the single biggest disconnect in the financial story and the reason we trust cash flow over earnings here.
Three things to take away. (1) The gap between net income and operating cash flow this decade is overwhelmingly depreciation and impairments - structural, not accounting fraud. (2) FCF was negative in FY2019, FY2022, and FY2023 - the trough of the cycle where the company was reactivating rigs with growth capex and unable to fund it from operations. (3) FY2025's $626M of FCF is the strongest reading since FY2015, driven by both higher operating cash flow ($749M, +68% YoY) and a sharp drop in capex.
FCF margin has now snapped back to 15.8% - reaching above the 10-year average of about 7%. Whether that holds depends on three line items below.
Two cash flow distortions deserve a closer look. Capex fell 52% YoY from $254M to $123M - that's well below the $660M of depreciation and below long-run maintenance capex of roughly $200-$300M. Some of that drop is timing (a major rig program rolling off); some reflects the strategic choice to scrap idle rigs rather than reactivate. If maintenance capex re-normalizes to $250M+ in FY2026, FCF would absorb that headwind. The $421M stock-issuance line in FY2025 financing is partly settlement of equity awards but mostly net equity issuance used to defease debt - the share count rose from 876M to 1,102M, a 26% one-year dilution that is not visible in FCF but very visible in per-share value.
Balance Sheet and Financial Resilience
Transocean is still a levered cyclical, but in clear deleveraging mode. Total debt has fallen from $7.41B at end-FY2023 to $5.66B at end-FY2025 - a $1.75B reduction in two years funded by a mix of asset sales, debt issuance refinancings, and equity issuance. Net debt is now $5.04B, the lowest level since FY2010.
Note the equity step-down in FY2025. Book equity fell from $10.29B to $8.11B - a $2.18B haircut almost equal to the impairment charges, partly offset by equity issuance. The result is that price-to-book moves from 0.32x at FY2024 close to 0.75x today not because the share price collapsed (it doubled in the last 12 months) but because book value shrank.
The financial resilience verdict is mixed. Liquidity is adequate (current ratio 1.56, $620M cash against $445M near-term debt) and credit rating has been improving (upgraded toward CCC+ on improved operating performance). But normalized net-debt-to-EBITDA of roughly 5.6x is still well above the 3x level that would unlock cheaper financing, and the FY2025 impairment cycle removed $2.6B of book equity in a single year. If day rates roll over before leverage falls to ~3x, this credit could see refinancing stress in the late 2020s.
Net leverage on normalized FY2025 EBITDA is roughly 5.6x. Management needs another full cycle year at or above current cash flow to drag this below 3x and reopen lower-cost financing.
Returns, Reinvestment, and Capital Allocation
This is the section where Transocean's ten-year accounting reality is hardest to defend. Return on invested capital has been negative for nine consecutive years.
Even excluding the FY2025 impairment, ROIC has hugged zero throughout the post-2017 era. The asset base ($15.6B of total assets, $12.6B of net property) earns essentially nothing through the cycle. The bull thesis is that with day rates now in recovery, FY2026-2027 ROIC will turn positive for the first time since FY2016. The bear thesis is that each cycle requires another wave of impairment to keep the book reflective of usable rigs, which structurally caps cumulative returns.
Management's capital allocation choice in FY2025 was unambiguous: throw every free dollar (and then some, via fresh equity) at the debt stack. No dividend, no buyback, modest capex, and $421M of equity issuance combined with $626M of FCF to fund $1.56B of debt paydown. That is the right move at this leverage level; it is also the reason per-share value has lagged enterprise-value recovery.
The share count has more than tripled from 364M in FY2015 to 1,102M at end FY2025. That is a 12% per-year dilution rate over a decade - far above what any rig fleet can outgrow. Capital allocation has been heroic on debt paydown but punitive on equity holders. Watching the share count flatten will be a key signal that the deleveraging phase is ending.
Segment and Unit Economics
Transocean publishes its segment data largely by rig class - ultra-deepwater floaters and harsh-environment semisubmersibles - and the company is effectively a pure-play ultra-deepwater driller after divesting the jackup business. Detailed audited segment revenue by rig class is not separated in the structured financial files we have, so we describe the economics qualitatively from the operating data.
The unit economic equation is straightforward: contracted rig days × day rate × revenue efficiency, minus daily operating cost. Ultra-deepwater drillship day rates have moved from sub-$200K in 2020 to leading-edge contracts above $480K-$500K in late 2025; the fleet-wide revenue efficiency reported around the Q1 FY2026 release was 96.5%, near best-in-class operationally. Contract backlog (multi-year drilling commitments) supports revenue visibility into 2026-2028, which is what the bulls anchor on. The risk: any pullback in oil prices and ultra-deepwater contracting cools quickly, and idle rigs accrue ~$60K-$80K/day of stacking costs.
Valuation and Market Expectations
At $6.37 the stock trades cheap on free cash flow but mid-pack to drilling peers on enterprise value to revenue. The valuation is a debate between two truths: a) FCF yield is 13.8% on FY2025 numbers, which is unambiguously attractive, and b) the company has not earned its cost of capital in nine years and remains sub-investment grade.
EV/Sales of 2.3x is the lowest reading since the 2015 trough. Price/Book of 0.56x is closer to the historical median than the deep-cycle lows. The 11-year multiple history tells you that 2.5-3.0x EV/Sales is the cycle average when the business is roughly cash-flow break-even; today the business is genuinely cash-generative, so an EV/Sales below cycle average is doing real work on valuation.
The peer chart frames the central debate. On EV/Sales Transocean trades at 2.31x versus 2.88x (NE) and 3.08x (VAL) - roughly a 20-25% discount to the two closest direct competitors. On adjusted EV/EBITDA (using ~$900M of normalized FY2025 EBITDA ex-impairment) Transocean trades around 10.2x, in line with VAL (11.7x) and NE (9.4x). The discount on revenue but parity on adjusted EBITDA implies the market is paying RIG a lower price for the same operating earnings, which the bulls call cheap; the bears call it appropriate compensation for the higher leverage and credit rating.
Sell-side targets cluster between $3.50 (low) and $10.00 (high) with a median of roughly $5.50-$6.50 - consistent with the base case above. Consensus is split: roughly 4 Buy, 6 Hold, 3 Sell ratings as of recent months, with Barclays upgrading to Overweight in early May 2026 at an $8 target.
Peer Financial Comparison
The peer-set verdict is that Transocean has the largest revenue base of the pure-play drillers and the strongest FY2025 FCF margin (15.8%) outside of Noble. It also carries by far the most net debt ($5.04B vs $0.3-$1.6B for the others) and has the only deeply negative ROIC in the group because of the FY2025 impairment. The 20-25% EV/Sales discount to VAL and NE is therefore not a free lunch - it reflects real differences in balance-sheet quality and accounting volatility, but the absolute FCF yield and price-to-book are doing the work for the value case.
RIG generates more absolute free cash flow than any peer except Noble, but its enterprise value to revenue trades at a 20-25% discount to those two peers - the gap the bull case needs to close.
What to Watch in the Financials
What the financials confirm. The cyclical recovery is real and measurable. Revenue is rising, gross margin is widening, cash flow has flipped clearly positive, and the company is using cash and equity to compress the debt stack. Q4 2025 and Q1 2026 mark the first quarters in years where operating income, free cash flow, and net income were all positive simultaneously.
What the financials contradict. The market is paying RIG less per dollar of revenue than it pays Valaris or Noble - implying the recovery is fragile or the leverage is too heavy. Returns on capital are still deeply negative on any 12-month look-back, the share count has tripled since 2015, and a CCC+ credit rating is not consistent with the share-price strength of the last year.
The first financial metric to watch is the Q2 FY2026 free cash flow conversion ratio: whether operating cash flow continues to clear $200M per quarter and capex stays at or below $80M per quarter, generating an annualized FCF run-rate above $500M. That single metric, sustained over four quarters, would lower net-debt-to-EBITDA below 4x by year-end 2026, force a credit upgrade, and close the EV/Sales discount to Valaris and Noble. Without it, the FY2025 impairment cycle could repeat in the next downturn and the leverage story unwinds.